Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights

Provided By GlobeNewswire

Last update: Sep 4, 2023

MONT-SAINT-GUIBERT, Belgium, Sept. 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces its financial results and recent business developments for the first half year, ended June 30, 2023.